Vitamin D status in children with congenital melanocytic nevi

Abstract

AbstractCongenital melanocytic nevi (CMN) are rare, pigmented birthmarks that can predispose patients to melanoma of the central nervous system and skin. Data from non‐CMN melanoma cohorts suggest that vitamin D levels may be connected to outcome, prompting this study of 25‐hydroxyvitamin D levels in plasma samples from 40 children with CMN. While 27% were insufficient and 13% deficient, this was representative of European populations, and UK supplementation guidelines are already in place. Our data support routine vitamin D supplementation for all CMN patients during winter months, without routine serum measurement.